Whether you require bulk supply, third-party manufacturing, private labeling, or export-ready injectable formulations, we are committed to supporting your pharmaceutical business growth
In its brief opposing the preliminary injunction, the FDA defends its data-driven conclusion that "Lilly's supply is currently exceeding demand and will meet or exceed projected demand across all strengths of Mounjaro and Zepbound." The FDA's determination relied heavily on confidential data provided by Lilly
Wu T, Bresee C, Wertheimer J, Hogg E, Malatt C, Tan E, et al
Contact Dermatitis 41(4):185189 Tornero P, De Barrio M, Baeza ML, Herrero T (2004) Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing
Inhibition of inflammatory gene expression in keratinocytes using a composition containing carnitine, thioctic acid and saw palmetto extract